Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Total Equity : ¥1,871 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Zhejiang East-Asia Pharmaceutical Co Total Equity?

Zhejiang East-Asia Pharmaceutical Co's total equity for the quarter that ended in Mar. 2025 was ¥1,871 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Zhejiang East-Asia Pharmaceutical Co Total Equity Historical Data

The historical data trend for Zhejiang East-Asia Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang East-Asia Pharmaceutical Co Total Equity Chart

Zhejiang East-Asia Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

1,729.57

1,758.09

1,839.77

2,015.27

1,874.74

Zhejiang East-Asia Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Equity	Get a 7-Day Free Trial															2,015.01	2,006.93	2,019.66	1,874.74	1,870.84

Zhejiang East-Asia Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Zhejiang East-Asia Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	3556.607	-	1681.871
	=	1,875

Zhejiang East-Asia Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2025 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2025 )	-	Total Liabilities(Q: Mar. 2025 )
	=	3485.835	-	1614.993
	=	1,871

Zhejiang East-Asia Pharmaceutical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Zhejiang East-Asia Pharmaceutical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang East-Asia Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang East-Asia Pharmaceutical Co Ltd (SHSE:605177) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 118, Laodong North Road, 23rd Floor, Chamber of Commerce Building, Huangyan District, Zhejiang Province, Taizhou, CHN

Website

http://www.eapharm.cn

Zhejiang East-Asia Pharmaceutical Co Ltd is mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules. The company's main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, piperazine, ticlazole and so on.

Zhejiang East-Asia Pharmaceutical Co Headlines

No Headlines